Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Theranostics Année : 2024

Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth

Résumé

Rationale: 17 beta-estradiol (E2) can directly promote the growth of ER alpha-negative cancer cells through activation of endothelial ER alpha in the tumor microenvironment, thereby increasing a normalized tumor angiogenesis. ER alpha acts as a transcription factor through its nuclear transcriptional AF-1 and AF-2 transactivation functions, but membrane ER alpha plays also an important role in endothelium. The present study aims to decipher the respective roles of these two pathways in ER alpha-negative tumor growth. Moreover, we delineate the actions of tamoxifen, a Selective Estrogen Receptor Modulator (SERM) in ER alpha-negative tumors growth and angiogenesis, since we recently demonstrated that tamoxifen impacts vasculature functions through complex modulation of ER alpha activity.Methods: ER alpha-negative B16K1 cancer cells were grafted into immunocompetent mice mutated for ER alpha-subfunctions and tumor growths were analyzed in these different models in response to E2 and/or tamoxifen treatment. Furthermore, RNA sequencings were analyzed in endothelial cells in response to these different treatments and validated by RT-qPCR and western blot.Results: We demonstrate that both nuclear and membrane ER alpha actions are required for the pro-tumoral effects of E2, while tamoxifen totally abrogates the E2-induced in vivo tumor growth, through inhibition of angiogenesis but promotion of vessel normalization. RNA sequencing indicates that tamoxifen inhibits the E2-induced genes, but also initiates a specific transcriptional program that especially regulates angiogenic genes and differentially regulates glycolysis, oxidative phosphorylation and inflammatory responses in endothelial cells.Conclusion: These findings provide evidence that tamoxifen specifically inhibits angiogenesis through a reprogramming of endothelial gene expression via regulation of some transcription factors, that could open new promising strategies to manage cancer therapies affecting the tumor microenvironment of ER alpha-negative tumors.
Fichier principal
Vignette du fichier
v14p0249.pdf (6.71 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04384793 , version 1 (10-01-2024)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Chanaëlle Febrissy, Marine Adlanmerini, Christel Péqueux, Frederic Boudou, Melissa Buscato, et al.. Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth. Theranostics, 2024, Theranostics, 14 (1), pp.249-264. ⟨10.7150/thno.87306⟩. ⟨hal-04384793⟩
34 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More